Details of the Drug

General Information of Drug (ID: DMP7MRC)

• Drug Name: Bulleyaconitine A
• Synonyms: XEL-002BP; Bulleyaconitine A (transdermal matrix patch/sustained release, pain); Bulleyaconitine A (transdermal matrix patch/sustained release, pain), Xel Pharmaceuticals

Indication

Disease Entry	ICD 11	Status	REF
Pain	MG30-MG3Z	Investigative	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C35H49NO9
  Canonical SMILES: CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6(CC4C5C6C(=O)C7=CC=C(C=C7)OC)O)OC)OC(=O)C)OC)OC)COC
  InChI: InChI=1S/C35H49NO9/c1-8-36-17-32(18-40-3)14-13-23(42-5)35-22-15-33(39)24(43-6)16-34(45-19(2)37,27(31(35)36)29(44-7)30(32)35)25(22)26(33)28(38)20-9-11-21(41-4)12-10-20/h9-12,22-27,29-31,39H,8,13-18H2,1-7H3/t22-,23+,24+,25-,26+,27-,29+,30-,31?,32+,33+,34-,35+/m1/s1
  InChIKey: YRECILNLFWZVRM-JNQVLWDESA-N
• Cross-matching ID:
  PubChem CID: 24721310
  TTD ID: D04ATY
• Drug Pharmacogenomic Perturbation (DPP)NEW: Click to Jump to the Detailed DPP Information of This Drug

References

• [1] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.